Petr Szturz

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


43 publications

2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
2024
 
Assessment of endpoint definitions in curative-intent trials for mucosal head and neck squamous cell carcinomas: Head and Neck Cancer International Group consensus recommendations.
Lim A.M., McDowell L., Hurt C., Le Tourneau C., Homma A., Shenouda G., Thomson D.J., Moya-Plana A., Henson C., Szturz P. et al., 2024/07. The Lancet. Oncology, 25 (7) pp. e318-e330. Peer-reviewed.
[DOI][Pmid][serval:BIB_5888F58ED735]
 
Assessment of endpoint definitions in recurrent and metastatic mucosal head and neck squamous cell carcinoma trials: Head and Neck Cancer International Group consensus recommendations.
Lim A.M., Le Tourneau C., Hurt C., Laskar S.G., Steuer C.E., Chow VLY, Szturz P., Henson C., Day A.T., Bates J.E. et al., 2024/07. The Lancet. Oncology, 25 (7) pp. e308-e317. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_AF66A4CF28EE]
 
Reirradiation of head and neck squamous cell carcinomas: a pragmatic approach-part I: prognostic factors and indications to treatment.
Alterio D., Zaffaroni M., Bossi P., Dionisi F., Elicin O., Falzone A., Ferrari A., Jereczek-Fossa B.A., Sanguineti G., Szturz P. et al., 2024/01. La Radiologia medica, 129 (1) pp. 160-173. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1B37A4813CBC]
2023
Managing cisplatin-ineligible patients with resected, high-risk, locally advanced squamous cell carcinoma of the head and neck: Is there a standard of care?
Haddad R.I., Harrington K., Tahara M., Szturz P., Le Tourneau C., Salmio S., Bajars M., Lee N.Y., 2023/09. Cancer treatment reviews, 119 p. 102585. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_5948D827C4E9]
 
Reirradiation of head and neck squamous cell carcinomas: a pragmatic approach, part II: radiation technique and fractionations.
Alterio D., Zaffaroni M., Bossi P., Dionisi F., Elicin O., Falzone A., Ferrari A., Jereczek-Fossa B.A., Sanguineti G., Szturz P. et al., 2023/08. La Radiologia medica, 128 (8) pp. 1007-1021. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_89918BD1D7ED]
Phase 4 Multinational Multicenter Retrospective and Prospective Real-World Study of Nivolumab in Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck.
Gogate A., Bennett B., Poonja Z., Stewart G., Medina Colmenero A., Szturz P., Carrington C., Castro C., Gemmen E., Lau A. et al., 2023/07/09. Cancers, 15 (14) p. 3552. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_95F216A17E04]
Defining the role of real-world data in cancer clinical research: The position of the European Organisation for Research and Treatment of Cancer.
Saesen R., Van Hemelrijck M., Bogaerts J., Booth C.M., Cornelissen J.J., Dekker A., Eisenhauer E.A., Freitas A., Gronchi A., Hernán M.A. et al., 2023/06. European journal of cancer, 186 pp. 52-61. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A0B1CC3E26F8]
Cancers des glandes salivaires : nouvelles approches thérapeutiques [Salivary gland cancer: new therapeutic approaches]
Herrera Gomez R.G., Mederos N., Szturz P., Degrauwe N., Jankovic J., Cristina V., 2023/05/17. Revue medicale suisse, 19 (827) pp. 958-963. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_44E8BFC57D5D]
 
Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma in Older Patients: Are New Agents Bringing New Hope?
Cossu Rocca M., Lorini L., Szturz P., Bossi P., Vermorken J.B., 2023/02. Drugs & aging, 40 (2) pp. 135-143. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4C168665F905]
Diagnostic challenges and prognostic implications of extranodal extension in head and neck cancer: a state of the art review and gap analysis.
Henson C.E., Abou-Foul A.K., Morton D.J., McDowell L., Baliga S., Bates J., Lee A., Bonomo P., Szturz P., Nankivell P. et al., 2023. Frontiers in oncology, 13 p. 1263347. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_92E590E95450]
Editorial: Head and neck cancer in the elderly.
Szturz P., Vermorken J.B., 2023. Frontiers in oncology, 13 p. 1218274. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BEFAA76D6472]
2022
Estimating the Prevalence of a True Oligometastatic Disease.
Szturz P., Bonomo P., Vermorken J.B., 2022/12/30. Cancers, 15 (1) p. 214. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_56F0255A14F5]
Steering decision making by terminology: oligometastatic versus argometastatic.
Szturz P., Vermorken J.B., 2022/09. British journal of cancer, 127 (4) pp. 587-591. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4166A465DB55]
The Screening and COnsensus Based on Practices and Evidence (SCOPE) Program Results of a Survey on Daily Practice Patterns for Patients with Metastatic Colorectal Cancer-A Swiss Perspective in the Context of an International Viewpoint.
Siebenhüner A.R., Lo Presti G., Helbling D., Szturz P., Astaras C., Buccella Y., De Dosso S., 2022/08/06. Current oncology, 29 (8) pp. 5604-5615. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AB0867D1DFC7]
 
Aggressive systemische Mastozytose mit erhöhter diffuser 18F-FDG-Aufnahme im Knochenmark [Aggressive systemic mastocytosis with diffuse bone marrow 18F-FDG uptake]
Koukalová R., Vašina J., Štika J., Doubek M., Szturz P., 2022/02. Nuklearmedizin. Nuclear medicine, 61 (1) pp. 58-61. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1CE439DEB48E]
Gallbladder cancer during pregnancy treated with surgery and adjuvant gemcitabine: A case report and review of the literature.
Diciolla A., Gianoni M., Fleury M., Szturz P., Demartines N., Peters S., Duran R., Desseauve D., Panchaud M.A., Fasquelle F. et al., 2022. Frontiers in oncology, 12 p. 1006387. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_83C6E9C8B673]
2021
 
Revisiting EXTREME in the Immuno-Oncology Era: How to Improve Its Outcomes.
Szturz P., Vermorken J.B., 2021/11. The oncologist, 26 (11) pp. 899-901. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_76CC0689FF16]
 
Prognostic factor analysis and long-term results of the TAX 323 (EORTC 24971) study in unresectable head and neck cancer patients.
Szturz P., Vinches M., Remenár É., van Herpen CML, Abdeddaim C., Stewart J.S., Fortpied C., Vermorken J.B., 2021/10. European journal of cancer, 156 pp. 109-118. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C29FF4897B51]
Oligometastatic Cancer: Key Concepts and Research Opportunities for 2021 and Beyond.
Szturz P., Vermorken J.B., 2021/05/21. Cancers, 13 (11) p. 2518. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_DDEE5B1D0575]
Carcinome anaplasique de la thyroïde : nouvelles approches thérapeutiques [Anaplastic thyroid carcinoma : new therapeutic approaches]
Stamatiou A., Herrera-Gómez R.G., Szturz P., Bisig B., Romano E., Sykiotis G., Gorostidi F., La Rosa S., Kopp P., Cristina V., 2021/05/19. Revue medicale suisse, 17 (739) pp. 962-966. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_E0FB351F6891]
 
Treatment landscape of metastatic pancreatic cancer.
De Dosso S., Siebenhüner A.R., Winder T., Meisel A., Fritsch R., Astaras C., Szturz P., Borner M., 2021/05. Cancer treatment reviews, 96 p. 102180. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_55A027525A9C]
 
Advanced Gastric Cancer: Current Treatment Landscape and a Future Outlook for Sequential and Personalized Guide: Swiss Expert Statement Article.
Siebenhüner A.R., De Dosso S., Helbling D., Astaras C., Szturz P., Moosmann P., Pederiva S., Winder T., Von Burg P., Borner M., 2021. Oncology research and treatment, 44 (9) pp. 485-494. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0FE58A54D26A]
Case Report: Vasculitis Triggered by SIRT in a Patient With Previously Untreated Cholangiocarcinoma.
Stamatiou A., Jankovic J., Szturz P., Fasquelle F., Duran R., Schaefer N., Diciolla A., Digklia A., 2021. Frontiers in oncology, 11 p. 755750. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_441991FCB38E]
Lurbinectedin in Refractory Diffuse Malignant Peritoneal Mesothelioma: Report of Two Cases.
Gros L., Szturz P., Diciolla A., Kirchner V., Peters S., Schaefer N., Hubner M., Digklia A., 2021. Frontiers in oncology, 11 p. 704295. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E9DC9323568E]
Meta-Analysis on Induction Chemotherapy in Locally Advanced Nasopharyngeal Carcinoma.
Mané M., Benkhaled S., Dragan T., Paesmans M., Beauvois S., Lalami Y., Szturz P., Gaye P.M., Vermorken J.B., Van Gestel D., 2021/01. The oncologist, 26 (1) pp. e130-e141. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6E0B9B9E5AF3]
2020
Oligometastatic Disease Management: Finding the Sweet Spot.
Szturz P., Nevens D., Vermorken J.B., 2020/12/22. Frontiers in oncology, 10 p. 617793. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_72F5AC8F1919]
 
Overcoming frailty in recurrent and metastatic head and neck cancer.
Szturz P., Vermorken J.B., 2020/10. Oral oncology, 109 p. 104636. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_234F84438D93]
 
ESMO MANAGEMENT AND TREATMENT ADAPTED RECOMMENDATIONS IN THE COVID-19 ERA: HEAD AND NECK CANCERS
Bossi P., Piazza C., Szturz P., Balermpas P., Machiels J.P., 2020/09/02..
[serval:BIB_D05E642A4C5A]
 
Further clinical interpretation and implications of KEYNOTE-048 findings.
Szturz P., Vermorken J.B., 2020/08/08. Lancet, 396 (10248) p. 379. Peer-reviewed.
[DOI][Pmid][serval:BIB_F19E1A6BA09F]
 
Global Perspective: Head and Neck Cancers.
Szturz P., Vermorken J.B., 2020/08/05. dans ASCO-SEP 7th Edition., Benjamin P. Levy.
[serval:BIB_2C97F92DDB47]
Translating KEYNOTE-048 into practice recommendations for head and neck cancer.
Szturz P., Vermorken J.B., 2020/08. Annals of translational medicine, 8 (15) p. 975. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_EE9D83DE88C9]
 
Management of recurrent and metastatic oral cavity cancer: Raising the bar a step higher.
Szturz P., Vermorken J.B., 2020/02/01. Oral oncology, 101 p. 104492. Peer-reviewed.
[DOI][Pmid][serval:BIB_CBE719CA5F22]
 
Do not de-escalate oncology care in oropharyngeal cancer routinely.
Szturz P., Vermorken J.B., 2020/01. Head & neck, 42 (1) pp. 143-144. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_60067256F5B4]
Follow-Up of Head and Neck Cancer Survivors: Tipping the Balance of Intensity.
Szturz P., Van Laer C., Simon C., Van Gestel D., Bourhis J., Vermorken J.B., 2020. Frontiers in oncology, 10 p. 688. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3FAFF518089A]
2019
 
18F-FDG positive colorectal polyp mimicing metastasis of advanced melanoma treated with ipilimumab
Koukalová K., Lakomý R., Fabian P., Řehák Z., Szturz P., 2019/12/01. Nukleární medicína, 8 (4) pp. 76-79. Peer-reviewed.
[serval:BIB_4F37351EC7B9]
Immunotherapies and Future Combination Strategies for Head and Neck Squamous Cell Carcinoma.
Cristina V., Herrera-Gómez R.G., Szturz P., Espeli V., Siano M., 2019/10/30. International journal of molecular sciences, 20 (21). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D6D634194460]
 
Systemic treatment in elderly head and neck cancer patients: recommendations for clinical practice.
Szturz P., Bossi P., Vermorken J.B., 2019/04. Current opinion in otolaryngology & head and neck surgery, 27 (2) pp. 142-150. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E76BF67C06EC]
Cisplatin Eligibility Issues and Alternative Regimens in Locoregionally Advanced Head and Neck Cancer: Recommendations for Clinical Practice.
Szturz P., Cristina V., Herrera Gómez R.G., Bourhis J., Simon C., Vermorken J.B., 2019. Frontiers in oncology, 9 p. 464. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_76EEE8FBE7D2]
Low-Dose vs. High-Dose Cisplatin: Lessons Learned From 59 Chemoradiotherapy Trials in Head and Neck Cancer.
Szturz P., Wouters K., Kiyota N., Tahara M., Prabhash K., Noronha V., Adelstein D., Van Gestel D., Vermorken J.B., 2019. Frontiers in oncology, 9 p. 86. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_78A5B254D97C]
 
Macrophages in the microenvironment of head and neck cancer: potential targets for cancer therapy.
Evrard D., Szturz P., Tijeras-Raballand A., Astorgues-Xerri L., Abitbol C., Paradis V., Raymond E., Albert S., Barry B., Faivre S., 2019/01. Oral oncology, 88 pp. 29-38. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3A5FCD94382F]
2018
 
Immune-modulating antibodies in head and neck cancer: past, present, and future
Szturz P., Vermorken J.B., 2018/12/01. Belgian Journal of Medical Oncology, 12 pp. 3-14. Peer-reviewed.
[serval:BIB_35E051ACC9B2]
 
Treatment of Elderly Patients with Head and Neck Cancer.
Szturz P., Vermorken J.B., 2018/11/13. pp. 285-307 dans Critical Issues in Head and Neck Oncology: Key Concepts from the Sixth THNO Meeting. chap. 20, Vermorken JB, Budach V, Leemans CR, Machiels JP, Nicolai P, O'Sullivan B (eds.)..
[DOI][serval:BIB_E8F242D68CED]
 
18F-FDG PET/CT pattern of Erdheim-Chester disease – a group of Czech patients
Řehák Z., Koukalová R., Vašina J., Ptáčník V., Szturz P., Karban J., Polívka J., Adam Z., 2018/09/01. Nukleární medicína, 7 (3) pp. 50-56. Peer-reviewed.
[serval:BIB_229461E6312E]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University